NO141801C - Fremgangsmaate for fremstilling av tiazolidinoneddiksyrederivater - Google Patents

Fremgangsmaate for fremstilling av tiazolidinoneddiksyrederivater

Info

Publication number
NO141801C
NO141801C NO750983A NO750983A NO141801C NO 141801 C NO141801 C NO 141801C NO 750983 A NO750983 A NO 750983A NO 750983 A NO750983 A NO 750983A NO 141801 C NO141801 C NO 141801C
Authority
NO
Norway
Prior art keywords
tiazolidinone
procedure
preparation
acetic acid
acid derivatives
Prior art date
Application number
NO750983A
Other languages
English (en)
Norwegian (no)
Other versions
NO750983L (en(2012)
NO141801B (no
Inventor
Gerhard Satzinger
Manfred Franz Reinhol Herrmann
Karl-Otto Vollmer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2414345A external-priority patent/DE2414345C3/de
Priority claimed from DE2506410A external-priority patent/DE2506410C3/de
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO750983L publication Critical patent/NO750983L/no
Publication of NO141801B publication Critical patent/NO141801B/no
Publication of NO141801C publication Critical patent/NO141801C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO750983A 1974-03-25 1975-03-21 Fremgangsmaate for fremstilling av tiazolidinoneddiksyrederivater NO141801C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2414345A DE2414345C3 (de) 1974-03-25 1974-03-25 (Z)-(3-Methyl-4-oxo-5-piperidinothiazolidin-2-yIiden)-esssigsäure und Verfahren zur Herstellung von Thiazolidinessigsäure-Derivaten
DE2506410A DE2506410C3 (de) 1975-02-15 1975-02-15 Verfahren zur Herstellung von Thiazolidinon-essigsäure-Derivaten

Publications (3)

Publication Number Publication Date
NO750983L NO750983L (en(2012)) 1975-09-26
NO141801B NO141801B (no) 1980-02-04
NO141801C true NO141801C (no) 1980-06-04

Family

ID=25766870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750983A NO141801C (no) 1974-03-25 1975-03-21 Fremgangsmaate for fremstilling av tiazolidinoneddiksyrederivater

Country Status (10)

Country Link
AT (1) AT340416B (en(2012))
CH (1) CH594664A5 (en(2012))
DK (1) DK140725B (en(2012))
ES (1) ES435930A1 (en(2012))
FI (1) FI59801C (en(2012))
FR (1) FR2265375B1 (en(2012))
GB (1) GB1437170A (en(2012))
NL (1) NL7503395A (en(2012))
NO (1) NO141801C (en(2012))
SE (1) SE415352B (en(2012))

Also Published As

Publication number Publication date
FR2265375B1 (en(2012)) 1978-08-04
DK140725B (da) 1979-11-05
SE415352B (sv) 1980-09-29
FI59801B (fi) 1981-06-30
FI750895A7 (en(2012)) 1975-09-26
FI59801C (fi) 1981-10-12
DK140725C (en(2012)) 1980-03-31
CH594664A5 (en(2012)) 1978-01-13
SE7503380L (en(2012)) 1975-09-26
NO750983L (en(2012)) 1975-09-26
NO141801B (no) 1980-02-04
ES435930A1 (es) 1977-03-16
ATA229075A (de) 1977-04-15
FR2265375A1 (en(2012)) 1975-10-24
DK108675A (en(2012)) 1975-09-26
AT340416B (de) 1977-12-12
NL7503395A (nl) 1975-09-29
GB1437170A (en(2012)) 1976-05-26

Similar Documents

Publication Publication Date Title
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
NO145247C (no) Fremgangsmaate for fremstilling av clavulansyre
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE7803860L (sv) Forfarande for framstellning av 7-d-(-)-alfa-amino-alfa(p-hydroxifenylacetamido)desacetoxicefalosporansyra
SE7613565L (sv) Forfarande for framstellning av fusidinsyraderivat
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE419646B (sv) Forfarande for framstellning av 8-halogen-dibensofuran-3-ettiksyra-derivat
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE416469B (sv) Forfarande for framstellning av aralkansyror innehallande dihydrofuran - eller dihydropyranringar
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
NO144525C (no) Fremgangsmaate til fremstilling av salter av klorerte eddiksyrer
SE7614091L (sv) Forfarande for framstellning av tiadiazolylderivat av 7-acylamido-3-cefem-4-karbonsyra
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7607322L (sv) Forfarande for framstellning av 16-etrar av fusidinsyraderivat
SE418395B (sv) Forfarande for framstellning av indanettiksyror
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE428564B (sv) Forfarande for framstellning av klavulansyraderivat
NO141801C (no) Fremgangsmaate for fremstilling av tiazolidinoneddiksyrederivater
SE427037B (sv) Forfarande for framstellning av deoxiklavulansyra
SE410313B (sv) Forfarande for framstellning av 20-alkoxi-16-alkyl-prostadiensyraderivat
SE428563B (sv) Forfarande for framstellning av acylerade klavulansyraderivat
SE7510547L (sv) Forfarande for framstellning av ftalaldehydsyra